Superior thermal performance and enhanced usability for PCR applications, such as sequencing, cloning, and genotyping.
TRIMERO Diagnostics offers IVD CE urinary assays of low molecular weight proteins, by nephelometry or turbidimetry, for the assessment of renal tubular function:
respons®940 is an automated random access clinical chemistry analyzer and offers a constant throughput of minimum 400 tests/h, independently whether a mono- or two component reagent is used. Including the optionally available ISE module with additional 240 test/h the total throughout increases to 640 tests/h.
INTEGRA Biosciences is excited to announce the launch of MIRO CANVAS, a compact digital microfluidics platform for fully automated next generation sequencing (NGS) sample preparation. The revolutionary system drastically simplifies NGS workflows for more walk-away time and higher lab productivity, accelerating genomics discoveries.
The new Beck Medical IML presented at the trade fair is a high-precision manufacturing system specially designed for the production of medical components. The application is part of a joint project with partners ARBURG, Intravis, KEBO and MCC Verstraete. The partners set themselves the goal of developing a system that enables high-precision IML in large […]
TRIMERO Diagnostics offers CE marked IVD assays for KAPPA and LAMBDA light chains (bound and free), for both urine and serum samples.
For years, capturing detailed three-dimensional images of complex biological specimens has posed a major challenge due to their intricate composition and the multiple scattering of light. A game-changing moment has arrived, as scientists from the MIT Laser Biomedical Research Center and the Chinese University of Hong Kong have introduced an innovative method called speckle diffraction […]
A powerful new antibiotic, isolated from bacteria that could not be studied before, seems capable of combatting harmful bacteria and multi-drug resistant ‘superbugs’. Named Clovibactin, the antibiotic appears to kill bacteria in an unusual way, making it more difficult for bacteria to develop resistance against it.
The European Medicines Agency (EMA) has recommended granting a marketing authorisation in the European Union (EU) for Pfizer Europe’s Abrysvo ( EMA opinion on Abrysvo: https://bit.ly/45jVL7Z ), a vaccine to protect against disease caused by the respiratory syncytial virus (RSV). Abrysvo is the first RSV vaccine indicated for passive immunisation of infants from birth through […]
UK Health Security Agency opens advanced Vaccine Development and Evaluation Centre
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
